In contrast, combination of methylated SCD2 with SEPT9 in ColoDefense® panel yielded a high CRC sensitivity and specificity of 88.9% (104/117) and 92.8% (154/166), however with a moderate APL detection accuracy of 47.8% (11/23) [78]. The gene discussed is SEPTIN9; the disease is colorectal carcinoma.